Director, Oncology Clinical Affairs (MD) — Medical Strategy

AOSW; Tucson (AZ); On-site; USD 250,000 - 380,000; Full time

Job summary

Corcept is seeking a Director, Oncology Clinical Affairs (MD) to lead high-level clinical and scientific engagement with external oncology experts and act as a bridge across Clinical Development, Medical Affairs, Commercial, Market Access, HEOR, Pharmacovigilance, and Regulatory partners.

The role supports Corcept’s medical affairs strategy, engages with physicians, and helps shape the introduction of Lifyorli in clinical practice in the US market.

Qualifications

• MD required.
• Oncology experience required; gynecologic oncology experience preferred.
• 3-5+ years of relevant oncology practice (including fellowship).
• Understanding of the U.S. healthcare environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry.
• Strong oral, written, and presentation skills, with the ability to communicate complex clinical concepts clearly to internal and external audiences.
• Collaborative, cross-functional leadership style with sound judgment, scientific rigor, and the ability to operate effectively in a launch-focused, evolving environment.

Responsibilities

• Provide clinical and scientific engagement with external oncology experts and serve as a bridge between Clinical Development, Medical Affairs, Commercial, Market Access, HEOR, Pharmacovigilance, and Regulatory partners.
• Lead high-level peer-to-peer scientific interactions with oncology experts, key opinion leaders (KOLs), clinical researchers, academic centers, and other external medical stakeholders.
• Represent Corcept at key medical conferences and external events as an internal clinical expert and external medical ambassador.

Education

MD

Job description

Corcept is seeking a Director, Oncology Clinical Affairs (MD) to lead high-level clinical and scientific engagement with external oncology experts and act as a bridge across Clinical Development, Medical Affairs, Commercial, Market Access, HEOR, Pharmacovigilance, and Regulatory partners.

The role supports Corcept’s medical affairs strategy, engages with physicians, and helps shape the introduction of Lifyorli in clinical practice in the US market.